Clinical Trial Update: Nilotinib in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating nilotinib for newly diagnosed chronic phase chronic myeloid leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Nilotinib (nilotinib)

Snippet

Sponsor: Cancer Trials Ireland | Conditions: Leukemia | Phase 2 | Status: COMPLETED